International Journal of Applied Research
Vol. 2, Issue 4, Part F (2016)
Effect of Monteleukast and Inhaled Corticosteroids in Asthma Disease: A Systemic Review
Asthma is a chronic inﬂammatory disorder of the airways characterized by recurrent symptoms associated with airﬂow limitation and by bronchial hyper responsiveness. Inhaled corticosteroids, which suppress airway inﬂammation, are efficient in reducing symptoms and exacerbations, and often normalize lung function. The most commonly used drugs like monteleukast and budesonide (inhaled corticosteroids) are given for the treatment of Asthma. The diagnosis is confirmed with the spirometry, chest x-Ray, FEV1 (forced expiratory volume in one second). Patients have been carefully assessed and characterized in terms of diagnosis, severity of asthma, aggravating factors and associated diseases. Inhaled rapid-acting β2- agonists are the preferred reliever medications for the treatment of acute symptoms, and should be prescribed to all patients with asthma. ICSs are the most effective anti-inflammatory medications available for the treatment of asthma and represent the mainstay of therapy for most patients with the disease. Antileukotrienes are a new class of anti-inflammatory agents which either interfere with the leukotriene receptors or leukotriene production.
How to cite this article:
Ravneet Kaur, Sourabh kosey, Raj Kumar, Mandeep kaur. Effect of Monteleukast and Inhaled Corticosteroids in Asthma Disease: A Systemic Review. Int J Appl Res 2016;2(4):370-374.